INTRODUCTION
Respiratory distress is one of the most common problem occurring; 5% in term and 29% in preterm babies requiring admission in Neonatal Intensive Care Unit (NICU) leading to 20% of neonatal deaths. [1] [2] [3] Saeed Z et al. described respiratory distress as the most common presenting problem encountered within the first 48-72 hours of life with a prevalence of 4.24% in neonates. 4 Hyaline Membrane Disease (HMD), Meconium Aspiration Syndrome (MAS), septicemia, congenital pneumonia, Transient Tachypnea of Newborn (TTN) are the major causes of respiratory distress in preterm, term and post Free Full Text Articles are Available at www.jnma.com.np term neonates. 5 Continuous Positive Airway Pressure (CPAP) is an effective therapy for managing respiratory distress in preterm, term and post term neonates. 6 CPAP is the application of positive pressure (4-6 cm of water) to the airways of spontaneously breathing babies throughout the respiratory cycle to reduce work of breathing, preventing lung collapse by maintaining functional residual capacity.
7-10
The main objective of this study was to observe the outcome of respiratory distress in neonates with Bubble CPAP (B-CPAP).
METHODS
This was a descriptive cross-sectional study done at 10 bedded NICU of Pediatrics Department, Kathmandu Medical College Teaching Hospital (KMCTH), Sinamangal, Kathmandu. Perinatal Mortality Rate (PMR) of this tertiary hospital is 10/1000 births and Neonatal mortality rate (NMR) is 4.5 /1000 live births.
11 Ethical clearance was received from Institutional Review Committee (IRC) of Kathmandu Medical College and written consent was taken from parents after explaining the baby's condition requiring B-CPAP therapy. B-CPAP is a non-invasive ventilation to deliver CPAP in a spontaneously breathing newborn to maintain lung volumes during expiration. 12 The study period was of six months (October 2018 to March 2019) duration. All preterm, term and post term babies born at KMCTH with respiratory distress due to any cause eg. Hyaline membrane disease (HMD), Meconium Aspiration Syndrome (MAS), septicemia, congenital pneumonia, Transient Tachypnea of Newborn (TTN) and perinatal asphyxia were included in this study. Syndromic babies and lethal congenital anomalies (eg. meningomyelocel, anencephaly, gastroschisis and diaphragmatic hernia) were excluded. 
RESULTS
There were total of 63 babies with respiratory distress included in this study. . Three babies died due to septicemia with DIC and one baby died due to pulmonary hemorrhage. The commonest complication of B-CPAP seen in 10 (16%) neonates was superficial skin abrasion under the nose and over the cheeks. Four (6%) babies each had gastric distension and acquired secondary infection whereas 1 (2%) each had right sided pneumothorax and recurrent apnea respectively ( Table 2) . 
Gastric distension 4
Right sided Pneumothorax 1
Recurrent Apnea 1
Total 63 (100)
The study highlighted that mean duration of B-CPAP use within 24 hrs was 94.47±36.9 hrs and after 24 hrs was 128±13.8 hrs (Table 3) .
Before B-CPAP, the mean respiratory rate was 83.02±7/ min, which had decreased after 48-96 hrs of B-CPAP. Similarly, the initial PEEP required before B-CPAP was 5.63±0.6cm of water, which was decreased after 48-96 hrs of B-CPAP. It showed decreasing trend of respiratory rate and PEEP pressure requirement after the use of B-CPAP (Table 3) . 
DISCUSSION
This descriptive cross-sectional study included all newborns (preterm and term) with respiratory distress who were treated with B-CPAP as the primary respiratory support. The included newborns were mostly term (71%) and 60% babies were of normal weight (2.5 -4 kg). The controversy of early vs delayed CPAP continues to have many trials favoring early CPAP were carried out to be better in the larger infants prior to routine use of antenatal steroids and postnatal surfactant. 15 The evidence suggested exogenous surfactant use with early CPAP with brief ventilation in extremely Low Birth Weight (ELBW) babies had decreased the use of mechanical ventilation. 16 Similarly, this study also showed B-CPAP within 24 hrs (early CPAP) in neonates with respiratory distress was effective in reducing respiratory effort and required lesser duration (94.47±36.9 hrs) of B-CPAP as compared to after 24 hrs (128±13.8 hrs). This finding was also strongly supported by the study done by Mathai SS et al, in which B-CPAP use within 24 hrs had less duration of B-CPAP (44.93±24.56 hrs) required as compared to after 24 hrs (85.57±54.16 hrs). 17 This study described the commonest cause of respiratory distress requiring B-CPAP was congenital pneumonia (23%) followed by MAS (19%), birth asphyxia (13%) and HMD (11%). Mathur NB et al. postulated congenital pneumonia as the main cause of respiratory distress (68%) with maternal history of PROM >24 hrs as one of the risk factor for it. 18 This study also corroborated similar findings as out of 15 babies with congenital pneumonia, nine babies had maternal history of PROM highlighting it as one of the major risk factor. Lanieta et al successfully demonstrated the usefulness of B-CPAP in developing countries highlighting its cost effectiveness. 19 Similarly in this study, out of 63 babies with B-CPAP 39 (61%) babies were improved.
Since, this is a single institutional study with convenient sampling, outcome might not be generalized. There are chances of selection bias.
CONCLUSIONS
This study concludes usefulness of Bubble Continuous Positive Airway Pressure in neonates with respiratory distress.
